Cocrystal Pharma Inc (COCP)
1.757
-0.05
(-2.94%)
USD |
NASDAQ |
Oct 31, 16:00
1.75
-0.01
(-0.39%)
After-Hours: 20:00
Cocrystal Pharma Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 0.51M |
| September 30, 2020 | 0.489M |
| June 30, 2020 | 0.554M |
| March 31, 2020 | 0.461M |
| December 31, 2019 | 0.402M |
| September 30, 2019 | 0.492M |
| June 30, 2019 | 0.592M |
| March 31, 2019 | 5.078M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | 0.024M |
| Date | Value |
|---|---|
| June 30, 2015 | 0.027M |
| March 31, 2015 | 0.027M |
| December 31, 2014 | 0.009M |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | -12.86M |
| September 30, 2012 | 4.734M |
| June 30, 2012 | 4.912M |
| March 31, 2012 | 3.51M |
| December 31, 2011 | 3.667M |
| September 30, 2011 | 3.930M |
| June 30, 2011 | 2.571M |
| March 31, 2011 | 2.798M |
| December 31, 2010 | 4.120M |
| September 30, 2010 | 4.515M |
| June 30, 2010 | 3.142M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.402M
Minimum
Dec 2019
0.554M
Maximum
Jun 2020
0.4832M
Average
0.489M
Median
Sep 2020
Revenue (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Alaunos Therapeutics Inc | 0.004M |
| Oragenics Inc | -- |
| Cara Therapeutics Inc | 0.991M |
| Jaguar Health Inc | 2.721M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.343M |
| Total Expenses (Quarterly) | 5.448M |
| EPS Diluted (Quarterly) | -0.53 |
| Enterprise Value | -0.2697M |
| Earnings Yield | -100.8% |
| Normalized Earnings Yield | -122.19 |